Banc of America Downgrades Cytyc

Analyst Kurt Kruger says the FTC vote against the Digene acquisition is a crushing blow, since the company had counted on it for the next leg of growth

Cytyc (CYTC ) shares fell after it announced that the Federal Trade Commission will block the acquisition of Digene. The company sees lower than expected EPS of break-even to $0.03 (pro forma).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.